EICHORCondition: Acute Myeloid Leukemia, in Relapse · Acute Myeloid Leukemia Refractory · Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
This is an observational (non-interventional), prospective, cohort study that will collects data from patients diagnosed with relapsed or refractory acute myeloid leukemia afferent to the participanting clinical sites
This description comes directly from the study's public registry record.
Oriana Nanni · +39 0543 739100 · cc.ubsc@irst.emr.it
Impact-aml coord Impact-aml coord · impact-aml@irst.emr.it
Always discuss trial participation with your own doctor first.
| University Hospital Aachen | Aachen, Germany | Recruiting |
| University Hospital Greifswald | Greifswald, Germany | Recruiting |
| University Hospital Halle | Halle, Germany | Recruiting |
| University Hospital of Rostock | Rostock, Germany | Recruiting |
| Policlinico Sant'Orsola-Malpighi | Bologna, BO, Italy | Recruiting |
| Ospedale "A. Perrino" | Brindisi, BR, Italy | Recruiting |
| ASST Spedali Civili | Brescia, BS, Italy | Recruiting |
| Azienda Ospedaliera S. Croce e Carle | Cuneo, CN, Italy | Recruiting |
| Ospedale Valduce | Como, CO, Italy | Recruiting |
| ASST Cremona | Cremona, CR, Italy | Recruiting |
| AOU Universitaria Arcispedale Sant'Anna | Ferrara, FE, Italy | Recruiting |
| IRCCS Ospedale Policlinico San Martino | Genova, GE, Italy | Recruiting |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06459024